Clinical Trials · NCT00239629
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 73
- Start date
- Sep 2005
- Locations
- 11 sites, 6 countries
- Primary endpoint
- The primary efficacy measure is the mineralization surface (MS%BS) evaluated in double tetracycline stained bone biopsies.